Flood chapter 25: Resp pharmacology Flashcards
Medications delivered to the lungs can have what effects
Direct effects on the airway
Systemic effects
Both direct and systemic
Pharm agents administered via the lungs allow for rapid uptake of drugs into ________or immediate ________
the blood stream
use by the cells of the airway
Action of inhaled anesthetics on the brain
Anesthesia
Action of inhaled anesthetics on the lungs
Bronchodilation
Direct effects of inhaled anesthetics
Bronchodilation from action on the lungs
Systemic effects of inhaled anesthetics
Anesthesia from action on the brain
Beta-adrenergic agonists delivered via aerosol exert direct effect on bronchial smooth muscle with few systemic effects. This would be an example of?
direct effect only
Drugs administered via airway are excellent for parenchymal diseases such as asthma and COPD because?
They take advantage of the rapid exposure to blood and pulmonary parenchymal cells.
Autonomic Nervous System (ANS) is divided into?
Divided into Sympathetic Nervous System (SNS) and Parasympathetic Nervous System (PNS)
Regulates airway caliber (diameter), airway, glandular activity and airway microvascular.
Parasympathetic Nervous System (PNS)
__________ provides the preganglionic fibers
Vagus Nerve
Preganglionic fibers synapse with postganglionic fibers in the_________
airway parasympathetic ganglia
Acetylcholine activates _____________ to produce bronchoconstriction.
the muscarinic (M3) receptor of postganglionic fibers of the PNS
Anticholinergics can provide bronchodilation even in the resting state because?
the PNS produces a basal level of resting bronchomotor tone.
Plays no direct role in control of airway muscle tone.
SNS
________ adrenergic receptors (a lot of them) are present on airway smooth muscle cells and cause bronchodilation (via stimulatory G mechanisms)
Beta-2
What is exact role of NANC?
Not well defined
It has excitatory and inhibitory neuropeptides that influence inflammation and smooth muscle tone respectively.
ANS also influences bronchomotor tone through
NANC system
the main inhibitory transmitters thought to be responsible for airway smooth muscle relaxation are?
Vasoactive Intestinal Peptide (VIP) and Nitric Oxide (NO)
The main excitatory transmitters shown to cause neurogenic inflammation, including bronchoconstriction are?
Substance P (SP) and Neurokinin A (NKA)
The mainstay therapy for bronchospasm, wheezing, and airflow obstruction is
Beta-adrenergic agonists.
Identify features of beta-adrenergic agonists used in clinical practice
Typically delivered via inhalers or nebulizers
Beta-2 selective
Divided into short and long acting therapies
Identify systemic adrenergic agonists
Terbutaline
Epinephrine
Albuterol
Identify short acting inhaled adrenergic agonists
Albuterol
Levalbuterol
Metaproterenol
Pirbuterol
Identify long acting inhaled adrenergic agonists
Salmeterol
Formoterol
Arformoterol
Name short acting Inhaled cholinergic antagonists
Ipratropium
Name long acting Inhaled cholinergic antagonists
Tiotropium
Name systemic cholinergic antagonists
Atropine
Scopolamine
Glycopyrrolate
Short acting Beta-2 Agonist Therapy is effective for
rapid relief of wheezing, bronchospasm and airflow obstruction.
____________ are used as maintenance therapy providing improved lung function and reduction in symptoms and exacerbations.
Long acting Beta-2 Agonists Therapy
Short acting Beta-2 agonists Bind to the Beta-2 adrenergic receptor located on the plasma membrane of
smooth muscle cells
epithelial
endothelial
and many other types of airway cells.
How does cAMP cause smooth muscle relaxation?
Not precisely known
Decreases in calcium release
Alterations in membrane potential
What unique properties allow for longer duration of action of LABA
Salmeterol has a longer duration because of a side that chain binds to the Beta-2 receptor and prolongs the activation of the receptor.
Formoterol has a lipophilic side chain allowing for interaction with the lipid bilayer of the plasma membrane. This allows a slow and steady release prolonging its duration of action.
Clinical effects of short acting B2 agonists is seen in minutes and lasts?
up to 4-6 hours.
Used primarily as rescue therapy
short acting B2 agonists
Long Acting B2 agonists are prescribed for?
Symptom control when short acting used > 2 x week
Combination therapy with inhaled corticosteroid where they are effective in reducing symptoms, reducing exacerbation and improving lung function while minimizing the dose of inhaled corticosteroids.
Combination therapy of LABA with inhaled corticosteroid are effective in
reducing symptoms
reducing exacerbation
improving lung function while minimizing the dose of inhaled corticosteroids.
B2 agonist side effects
Tremors
Tachycardia
Temporary reduction of PO2 of 5 mmHg In severe asthma
Hyperglycemia
Hypokalemia
Hypomagnesemia
Tremors and Tachycardia with B2 agonist is secondary to
Direct stimulation of the Beta-2 adrenergic receptor in skeletal muscle or vasculature.
Temporary reduction of PO2 of 5 mmHg In severe asthma with B2 agonist use is secondary to?
Beta-2 mediated vasodilation in poorly ventilated lung regions.
These side effects of B-2 agonist therapy tend to decrease with regular use.
Hyperglycemia
Hypokalemia
Hypomagnesemia
Beta-2 adrenergic Tolerance likely reflects?
Beta-2 adrenergic receptors down regulation
Withdrawal of a Beta-2 agonist after regular use can produce
transient bronchial hyperresponsiveness (exaggerated bronchial restriction)
_____ is not affected by B2 agonist tolerance
bronchodilation
Tolerance to Beta-2 agonists can occur with regular use over _______period
period of weeks
Evidence of Beta-2 agonists tolerance
Decrease in duration of bronchodilation
Decrease in magnitude of side effects (such as tremors and tachy etc.).
Use of _______ without concomitant use of a steroid inhaler as been shown to be associated with fatal and near-fatal asthma attacks.
long acting Beta-2 agonist therapy
Prudent to reserve long acting Beta-2 agonists for those pts who?
Are poorly controlled on inhaled steroids alone.
Have symptoms perilous enough to warrant the potential added risk.
B2 agonist Inhalation route should be first line treatment d/t
possibilities of side effects with IV formulations
The side effects of systemic adrenergic agonists is similar to inhalational adrenergic agonists with _________ being the most common.
tremors and tachy
Inhaled anticholinergics are used for
maintenance therapy and tx of acute exacerbations in obstructive disease
Use of _________ in COPD as maintenance and rescue therapy is standard treatment.
inhaled anticholinergics
Anticholinergics are used for maintenance therapy in asthma. True/False
False
Anticholinergics are NOT used for maintenance therapy in asthma. Only recommended for use in acute exacerbations.
3 subtypes of muscarinic receptors in the airway are
M2: Not targeted by inhaled anticholinergics
M1 and M3: Targets of inhaled anticholinergic therapy.
M2 receptors are responsible for?
Responsible for limiting production of Ach and protect against bronchoconstriction.
Is NOT the target of inhaled anticholinergic, but is antagonized by them.
Muscarinic 1 (M1) and Muscarinic 3 (M3): These receptors are responsible for
bronchoconstriction and mucus production and are the targets of inhaled anticholinergic therapy.
M1 and M3 receptor action
Acetylcholine binds to the M3 and M1 receptors and causes smooth muscle contraction.
This smooth muscle contraction is produced from increases in cyclic guanosine monophosphate (cGMP) or by activation of a G protein (Gq)
Gq activates phospholipase C to produce inositol triphosphate (IP3)
IP3 causes release of calcium from intracellular stores and activation of myosin light chain kinase causing smooth muscle contraction.
Anticholinergics inhibit this cascade and reduce smooth muscle tone by decreasing release of calcium from intracellular stores.
Ipratropium (Atrovent)
Classified as a short acting anticholinergic.
Commonly used as maintenance therapy for COPD.
Also used as rescue therapy or both COPD and asthmatic exacerbations (not indicated for routine management of asthma).
Ipratropium treatment increases in exercise tolerance, decrease in dyspnea, and improved gas exchange.
Tiotropium (Spiriva):
Only long acting anticholinergic available for COPD maintenance therapy.
Reduces COPD exacerbations, respiratory failure, and all-cause mortality
This drugs is associated with CV and CVA complications however, studies do not consistently support this claim
Tiotropium
Inhaled Anticholinergics _________ absorbed and serious side effects are uncommon
Poorly
Inflammatory cell types present in COPD
Neutrophils
macrophages
CD 8 + T lymphocytes
eosinophils
prominent cells in the inflammatory composition of Asthma
Eosinophils (Most)
mast cells (2nd most)
CD 4 + T lymphocytes
macrophages
Anti-Inflammatory response in COPD and asthma can be predicted by?
Inflammatory cell types present in sputum; biopsy specimens; and bronchoalveolar lavage fluid.
the primary target of ICS is?
Glucocorticoid receptor alpha (GRα) located in the cytoplasm of airway epithelial cells
In asthma, treatment with ICS will?
ICS reduces inflammatory changes associated with the disease.
Improves lung function; reducing exacerbations that result in hospitalization and death.
ICS treatment in COPD
ICS as a monotherapy is discouraged.
ICS are used in combination therapy with a long-actin B-adrenergic agonists (LABA).
The synergistic effect reduces inflammation
Combination of ICS and LABA are recommended for severe to very severe COPD pts.
ICS are added to the asthma regimen when ?
When there is an increase in frequency or severity of exacerbations
Evidence does show ICS decrease ___________ in asthma.
hospitalizations and deaths
Combination of ICS and LABA are recommended for
severe to very severe COPD pts.
ICS/LABA has been shown to improve mortality in COPD pts. T/F?
FALSE : It hasn’t been shown to improve mortality.
The combination has been reported to improve lung function and reduce exacerbations
Steroid receptor MOA
Steroid enters the cell through passive diffusion leading to binding of the steroid ligand to the glucocorticoid receptor alpha, dissociation of heat shock proteins, and subsequent translocation to the nucleus.
This complex can bind to promoter regions of DNA sequences and either induce or suppress gene expression.
Its can also Interact with transcription factors such as the one responsible for pro-inflammatory mediators (without binding to DNA) and repress expression of those genes
It can also affect chromatin structure; influence the winding of DNA; reduce access of RNA and thus reduce expression of inflammatory gene products
Passive diffusion of steroids into the cell allows for
Binding of the steroid ligand to the glucocorticoid receptor alpha.
Dissociation of heat shock proteins.
Subsequent translocation to the nucleus.
After translocation to the nucleus, the steroid- glucocorticoid receptor alpha complex can?
Bind to promoter regions of DNA sequences and either induce or suppress gene expression.
Interact with transcription factors such as the one responsible for pro-inflammatory mediators (without binding to DNA) and repress expression of those genes
Affect chromatin structure; influence the winding of DNA; reduce access of RNA and thus reduce expression of inflammatory gene products
ICS has reported increase in pneumonia and severe pneumonia in patients with?
COPD
However no reported increase in death
What are the side effects of ICS in patients with COPD and Asthma
candidiasis
pharyngitis
easy bruising
osteoporosis
cataracts
elevated intraocular pressure
dysphonia and growth retardation in children.
The recommended duration of Systemic corticosteroids in COPD patients should not exceed 2 weeks because
Side effects with No added benefit to longer duration.
In Asthma, systemic Corticosteroids are recommended for exacerbations that are?
Severe with a peak expiratory low of <40% of baseline.
Mild to moderate exacerbation with no immediate response to short acting Beta-adrenergic agonists.